Información de Insulet Corp, dividendo de Insulet Corp, actividades de los accionistas y más

Más Datos de Insulet Corp Compañía

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Información de la empresa

Código de la empresaPODD

Nombre de la empresaInsulet Corp

Fecha de salida a bolsaMay 15, 2007

Fundada en2000

Director ejecutivoMs. Ashley Mcevoy

Número de empleados3900

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 15

Dirección100 Nagog Park

CiudadACTON

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal01720-3440

Teléfono19786007000

Sitio Webhttps://www.omnipod.com

Código de la empresaPODD

Fecha de salida a bolsaMay 15, 2007

Fundada en2000

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

4.46K

--

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

+24.38%

Dr. Luciana Borio, M.D.

Independent Director

2.79K

--

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.12K

+53.26%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

Desglose de ingresos

Divisa: USDHora de actualización: dom., 6 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Por negocioUSD

Nombre

Ganancia

Proporción

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

1.55B

74.73%

All Other

523.40M

25.27%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

Accionista

Hora de actualización: vie., 21 de feb

Estadísticas de accionistas

Tipo

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

Estadísticas de accionistas

Accionista

Proporción

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

Tipo

Accionista

Proporción

Investment Advisor

55.61%

Investment Advisor/Hedge Fund

35.89%

Hedge Fund

3.60%

Research Firm

2.91%

Pension Fund

1.75%

Sovereign Wealth Fund

1.43%

Bank and Trust

1.36%

Private Equity

0.33%

Individual Investor

0.28%

Participación institucional

Hora de actualización: lun., 20 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

1508

72.93M

103.85%

-4.38M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

2023Q1

1206

74.71M

107.20%

-300.49K

2022Q4

1126

71.74M

103.30%

-3.89M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

8.46M

12.05%

+16.65K

+0.20%

Dec 31, 2024

Capital Research Global Investors

7.45M

10.6%

-326.10K

-4.20%

Dec 31, 2024

Fidelity Management & Research Company LLC

7.08M

10.08%

-246.09K

-3.36%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

4.25M

6.05%

+74.08K

+1.77%

Dec 31, 2024

State Street Global Advisors (US)

2.97M

4.24%

+59.55K

+2.04%

Dec 31, 2024

Baillie Gifford & Co.

2.36M

3.35%

+79.98K

+3.51%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.78M

2.53%

+40.57K

+2.33%

Dec 31, 2024

Fidelity International

1.43M

2.04%

-9.70K

-0.67%

Dec 31, 2024

ClearBridge Investments, LLC

1.41M

2%

-62.73K

-4.27%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

953.02K

1.36%

-911.00

-0.10%

Dec 31, 2024

ETFs relacionados

Hora de actualización: dom., 6 de abr

Nombre

Proporción

Langar Global HealthTech ETF

6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

5.13%

Goldman Sachs Future Health Care Equity ETF

4.71%

Global X Telemedicine & Digital Health ETF

4.21%

Fidelity Digital Health ETF

3.91%

Congress SMid Growth ETF

2.6%

Harbor Health Care ETF

2.32%

iShares U.S. Medical Devices ETF

2.03%

First Trust Health Care Alphadex Fund

1.8%

iShares Health Innovation Active ETF

1.76%

Langar Global HealthTech ETF

Proporción6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción5.13%

Goldman Sachs Future Health Care Equity ETF

Proporción4.71%

Global X Telemedicine & Digital Health ETF

Proporción4.21%

Fidelity Digital Health ETF

Proporción3.91%

Congress SMid Growth ETF

Proporción2.6%

Harbor Health Care ETF

Proporción2.32%

iShares U.S. Medical Devices ETF

Proporción2.03%

First Trust Health Care Alphadex Fund

Proporción1.8%

iShares Health Innovation Active ETF

Proporción1.76%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Insulet Corp

251.690USD

Insulet Corp

251.690

Descripción general

Compañía